Vahabi, S.M.; Bahramian, S.; Esmaeili, F.; Danaei, B.; Kalantari, Y.; Fazeli, P.; Sadeghi, S.; Hajizadeh, N.; Assaf, C.; Etesami, I.
JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature. Cancers 2024, 16, 861.
https://doi.org/10.3390/cancers16050861
AMA Style
Vahabi SM, Bahramian S, Esmaeili F, Danaei B, Kalantari Y, Fazeli P, Sadeghi S, Hajizadeh N, Assaf C, Etesami I.
JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature. Cancers. 2024; 16(5):861.
https://doi.org/10.3390/cancers16050861
Chicago/Turabian Style
Vahabi, Seyed Mohammad, Saeed Bahramian, Farzad Esmaeili, Bardia Danaei, Yasamin Kalantari, Patrick Fazeli, Sara Sadeghi, Nima Hajizadeh, Chalid Assaf, and Ifa Etesami.
2024. "JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature" Cancers 16, no. 5: 861.
https://doi.org/10.3390/cancers16050861
APA Style
Vahabi, S. M., Bahramian, S., Esmaeili, F., Danaei, B., Kalantari, Y., Fazeli, P., Sadeghi, S., Hajizadeh, N., Assaf, C., & Etesami, I.
(2024). JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature. Cancers, 16(5), 861.
https://doi.org/10.3390/cancers16050861
